Tristetraprolin exerts tumor suppressive functions on the tumorigenesis of glioma by targeting IL-13

Jungk, 2016, Chemotherapy with BCNU in recurrent glioma: analysis of clinical outcome and side effects in chemotherapy-naïve patients, BMC Cancer, 16, 81, 10.1186/s12885-016-2131-6 Wu, 2015, Peritumoral edema on magnetic resonance imaging predicts a poor clinical outcome in malignant glioma, Oncol. Lett., 10, 2769, 10.3892/ol.2015.3639 Li, 2016, Effect of photodynamic therapy combined with torasemide on the expression of matrix metalloproteinase 2 and sodium-potassium-chloride cotransporter 1 in rat peritumoral edema and glioma, Oncol. Lett., 11, 2084, 10.3892/ol.2016.4210 Lou, 2015, Satisfactory therapy results of combining nimustine with nicardipine against glioma at advanced stage, J. Cancer Res. Ther., 11, 1030, 10.4103/0973-1482.154033 Chaudhuri, 2014, The novel immunotherapeutic molecule T11TS modulates glioma-induced changes of key components of the immunological synapse in favor of T cell activation and glioma abrogation, J. Neuro-Oncol., 120, 19, 10.1007/s11060-014-1528-9 Eid, 2015, Genetic inactivation of ATRX leads to a decrease in the amount of telomeric cohesin and level of telomere transcription in human glioma cells, Mol. Cell. Biol., 35, 2818, 10.1128/MCB.01317-14 Claus, 2015, Survival and low-grade glioma: the emergence of genetic information, Neurosurg. Focus., 38, 10.3171/2014.10.FOCUS12367 Chu, 2016, Identification and verification of PRDX1 as an inflammation marker for colorectal cancer progression, Am. J. Transl. Res., 8, 842 Yang, 2015, Knockdown of PLCε inhibits inflammatory cytokine release via STAT3 phosphorylation in human bladder cancer cells, Tumour Biol., 36, 9723, 10.1007/s13277-015-3712-8 Zimmer, 2016, Impact of a half marathon on cellular immune system, pro-inflammatory cytokine levels, and recovery behavior of breast cancer patients in the aftercare compared to healthy controls, Eur. J. Haematol., 96, 152, 10.1111/ejh.12561 Fuss, 2014, IL-13Rα2-bearing, type II NKT cells reactive to sulfatide self-antigen populate the mucosa of ulcerative colitis, Gut, 63, 1728, 10.1136/gutjnl-2013-305671 Hua, 2016, Four-locus gene interaction between IL13, IL4, FCER1B, and ADRB2 for asthma in Chinese Han children, Pediatr. Pulmonol., 51, 364, 10.1002/ppul.23322 Li, 2016, Association between DNA hypomethylation at IL13 gene and allergic rhinitis in house dust mite-sensitized subjects, Clin. Exp. Allergy, 46, 298, 10.1111/cea.12647 Creery, 2006, Differential regulation of CXCR4 and CCR5 expression by interleukin (IL)-4 and IL-13 is associated with inhibition of chemotaxis and human immunodeficiency virus (HIV) type 1 replication but not HIV entry into human monocytes, Viral Immunol., 19, 409, 10.1089/vim.2006.19.409 Barderas, 2012, High expression of IL-13 receptor α2 in colorectal cancer is associated with invasion, liver metastasis, and poor prognosis, Cancer Res., 72, 2780, 10.1158/0008-5472.CAN-11-4090 Fujisawa, 2012, IL-13 regulates cancer invasion and metastasis through IL-13Rα2 via ERK/AP-1 pathway in mouse model of human ovarian cancer, Int. J. Cancer, 131, 344, 10.1002/ijc.26366 Xie, 2015, IL-13 receptor α2 is a negative prognostic factor in human lung cancer and stimulates lung cancer growth in mice, Oncotarget, 6, 32902, 10.18632/oncotarget.5361 Kunwar, 2007, Direct intracerebral delivery of cintredekin besudotox (IL13-PE38QQR) in recurrent malignant glioma: a report by the cintredekin besudotox intraparenchymal study group, J. Clin. Oncol., 25, 837, 10.1200/JCO.2006.08.1117 Fujisawa, 2011, Histone modification enhances the effectiveness of IL-13 receptor targeted immunotoxin in murine models of human pancreatic cancer, J. Transl. Med., 9, 37, 10.1186/1479-5876-9-37 Wang, 2015, Constitutive activation of interleukin-13/STAT6 contributes to Kaposi's sarcoma-associated herpes virus-related primary effusion lymphoma cell proliferation and survival, J. Virol., 89, 10416, 10.1128/JVI.01525-15 Hou, 2010, Expression of IL-13Ralpha2 in liver cancer cells and its effect on targeted therapy of liver cancer, J. Cancer Res. Clin. Oncol., 136, 839, 10.1007/s00432-009-0724-z Strober, 2009, The signaling function of the IL-13Ralpha2 receptor in the development of gastrointestinal fibrosis and cancer surveillance, Curr. Mol. Med., 9, 740, 10.2174/156652409788970652 Fujisawa, 2009, A novel role of interleukin-13 receptor alpha2 in pancreatic cancer invasion and metastasis, Cancer Res., 69, 8678, 10.1158/0008-5472.CAN-09-2100 Zhao, 2015, IL-13Rα2 mediates PNR-induced migration and metastasis in ERα-negative breast cancer, Oncogene, 34, 1596, 10.1038/onc.2014.53 Patial, 2016, Enhanced stability of tristetraprolin mRNA protects mice against immune-mediated inflammatory pathologies, Proc. Natl. Acad. Sci. U. S. A., 113, 1865, 10.1073/pnas.1519906113 Rahman, 2016, Activating protein phosphatase 2A (PP2A) enhances tristetraprolin (TTP) anti-inflammatory function in A549 lung epithelial cells, Cell. Signal., 28, 325, 10.1016/j.cellsig.2016.01.009 Goddio, 2012, Mammary differentiation induces expression of tristetraprolin, a tumor suppressor AU-rich mRNA-binding protein, Breast Cancer Res. Treat., 135, 749, 10.1007/s10549-012-2216-0 Lee, 2010, Tristetraprolin regulates expression of VEGF and tumorigenesis in human colon cancer, Int. J. Cancer, 126, 1817, 10.1002/ijc.24847 Shah, 2016, Negative feed-forward control of tumor necrosis factor (TNF) by tristetraprolin (ZFP36) is limited by the mitogen-activated protein kinase phosphatase, dual-specificity phosphatase 1 (DUSP1): IMPLICATIONS FOR REGULATION BY GLUCOCORTICOIDS, J. Biol. Chem., 291, 110, 10.1074/jbc.M115.697599 Xiao, 2014, The abnormal expressions of tristetraprolin and the VEGF family in uraemic rats with peritoneal dialysis, Mol. Cell. Biochem., 392, 229, 10.1007/s11010-014-2033-3 Barrios-García, 2016, Nuclear tristetraprolin acts as a corepressor of multiple steroid nuclear receptors in breast cancer cells, Mol. Genet. Metab. Rep., 7, 20, 10.1016/j.ymgmr.2016.02.004 Yoon, 2016, Tristetraprolin suppresses the EMT through the down-regulation of Twist1 and Snail1 in cancer cells, Oncotarget, 7, 8931, 10.18632/oncotarget.7094 Sobolewski, 2015, Histone deacetylase inhibitors activate tristetraprolin expression through induction of early growth response protein 1 (EGR1) in colorectal cancer cells, Biomolecules, 5, 2035, 10.3390/biom5032035 Shimamura, 2010, Interleukin 13 mediates signal transduction through interleukin 13 receptor alpha 2 in pancreatic ductal adenocarcinoma: role of IL-13 Pseudomonas exotoxin in pancreatic cancer therapy, Clin. Cancer Res., 16, 577, 10.1158/1078-0432.CCR-09-2015 Yan, 2010, Killing effect of interleukin-13 receptor alpha 2 (IL-13Ralpha2) sensitized DC-CTL cells on human glioblastomaU251 cells, Cell. Immunol., 263, 172, 10.1016/j.cellimm.2010.03.013 Li, 2016, IKKβ/NFκBp65 activated by interleukin-13 targets the autophagy-related genes LC3B and beclin 1 in fibroblasts co-cultured with breast cancer cells, Exp. Ther. Med., 11, 1259, 10.3892/etm.2016.3054 Bartolomé, 2015, IL13Rα2 signaling in colorectal cancer, Oncoscience, 2, 787, 10.18632/oncoscience.241 Suzuki, 2015, Targeting of IL-4 and IL-13 receptors for cancer therapy, Cytokine, 75, 79, 10.1016/j.cyto.2015.05.026 Huang, 2016, 6-Mercaptopurine attenuates tumor necrosis factor-α production in microglia through Nur77-mediated transrepression and PI3K/Akt/mTOR signaling-mediated translational regulation, J. Neuroinflammation, 13, 78, 10.1186/s12974-016-0543-5 Moriya, 2011, Expression of matrix metalloproteinase-13 is controlled by IL-13 via PI3K/Akt3 and PKC-δ in normal human dermal fibroblasts, J. Invest. Dermatol., 131, 655, 10.1038/jid.2010.361 Binger, 2015, High salt reduces the activation of IL-4- and IL-13-stimulated macrophages, J. Clin. Invest., 125, 4223, 10.1172/JCI80919